Driehaus Capital Management LLC Applied Therapeutics Inc. Transaction History

Driehaus Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.48 - $6.22 $765,318 - $3.22 Million	-517,107 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$8.77 - $18.29 $1.07 Million - $2.24 Million	-122,450 Reduced 19.15%	517,107 $4.63 Million
Q3 2021 Nov 15, 2021	SELL	$13.54 - $22.06 $62,730 - $102,203	-4,633 Reduced 0.72%	639,557 $10.6 Million
Q2 2021 Aug 16, 2021	BUY	$14.05 - $25.04 $66,484 - $118,489	4,732 Added 0.74%	644,190 $13.4 Million
Q1 2021 May 17, 2021	BUY	$16.57 - $28.65 $2.86 Million - $4.94 Million	172,479 Added 36.94%	639,458 $12 Million
Q4 2020 Feb 16, 2021	SELL	$15.44 - $24.23 $2.47 Million - $3.88 Million	-160,021 Reduced 25.52%	466,979 $10.3 Million
Q3 2020 Nov 16, 2020	SELL	$19.43 - $35.36 $2.47 Million - $4.5 Million	-127,261 Reduced 16.87%	627,000 $13 Million
Q2 2020 Aug 14, 2020	BUY	$29.41 - $51.23 $4.79 Million - $8.34 Million	162,780 Added 27.52%	754,261 $27.3 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $55.47 $10.4 Million - $29.5 Million	531,481 Added 885.8%	591,481 $19.3 Million
Q4 2019 Feb 12, 2020	BUY	$10.16 - $28.14 $609,600 - $1.69 Million	60,000 New	60,000 $1.64 Million

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $462M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.